This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: **Innovative Contributions of Jin-Man Kim in Cancer Research**
Introduction
Jin-Man Kim is a notable inventor based in Taejon, South Korea, recognized for his innovative research in cancer diagnostics. His work focuses on the SYG972 gene, which has significant implications in understanding and treating breast cancer. With one patent to his name, Kim's contributions reflect his dedication to advancing medical science through genetic research.
Latest Patents
The most prominent patent authored by Jin-Man Kim pertains to the "Cell growth inhibiting and cell differentiation specific SYG972 gene, genomic DNA and promoter thereof." This invention outlines a diagnostic method for cancer, utilizing the SYG972 gene. Notably, the expression of this gene is significantly reduced in breast cancer cells compared to normal breast cells, presenting a crucial avenue for cancer diagnostics. The patent details the genomic structure of the SYG972 gene, which consists of 4 exons and 3 introns, along with a 3 kb promoter responsible for regulating the gene's transcription. This genomic information serves as a foundation for designing drugs aimed at promoting or inhibiting apoptosis and differentiation in cancer cells.
Career Highlights
Jin-Man Kim is associated with Samyang Genex Corporation, where he continues to innovate and conduct research in genetic engineering and cancer therapy. His work has positioned him as a vital contributor to the company, pushing the boundaries of what is possible in medical applications of genetics.
Collaborations
Throughout his career, Jin-Man Kim has collaborated with expert colleagues, including Neon-Cheol Jung and Seung-Suh Hong. These partnerships foster a collaborative research environment that enhances the scope and quality of their collective contributions to cancer research and treatment alternatives.
Conclusion
Jin-Man Kim exemplifies the spirit of innovation in the field of genetics and cancer research. His patent on the SYG972 gene not only showcases his inventive capabilities but also marks a significant step forward in the diagnostic methods for cancer. With his ongoing work at Samyang Genex Corporation and collaborations with fellow researchers, Kim continues to inspire progress in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile